COVID-19 update: Oct. 6, 2022

CDC updates guidance on COVID-19 boosters

The Centers for Disease Control and Prevention (CDC) has updated their recommendations for vaccine boosters within each age group.

NIH updates guidance on influenza season and COVID-19

The National Institute of Health’s (NIH) COVID-19 Treatment Guidelines Panel has updated their recommendations for the upcoming influenza season. Read the latest recommendations from NIH.

Public comment closed Sept. 28

Summer 2022 public comment was open Aug. 3 through Sept. 28. Read all items and view feedback from the community.

The latest data on organ donation and transplant in the U.S.

Find high-level data on transplants, deceased donors recovered, patients added to the waitlist and patients temporarily moved to inactive waitlist status.

---

Reminders

Updated COVID-19 Summary of Evidence

• The OPTN Ad Hoc Disease Transmission Advisory Committee completed its quarterly update of the SARS-CoV-2 Summary of Evidence on Aug. 22, 2022. This version includes current information on Omicron sublineages BA.4/BA.5 as well as the most recent literature on SARS-CoV-2 and its effect on transplant.

FDA authorizes updated COVID-19 booster

• The Food and Drug Administration (FDA) has authorized the use of updated Moderna and Pfizer vaccines to protect against the Omicron variant of COVID-19 for use as a single booster dose at least two months following a primary or booster vaccination.

---

Questions

• For COVID-19 related policy and operational questions, email [email protected]
• For information and updates about the status of in-person vs. virtual OPTN committee meetings, check the OPTN calendar of events.